Gastroprotective effect of Cochinchina momordica seed extract in nonsteroidal anti-inflammatory drug-induced acute gastric damage in a rat model

Gut Liver. 2014 Jan;8(1):49-57. doi: 10.5009/gnl.2014.8.1.49. Epub 2013 Nov 5.

Abstract

Background/aims: The major compounds of Cochinchina momordica seed extract (SK-MS10) include momordica saponins. We report that the gastroprotective effect of SK-MS10 in an ethanol-induced gastric damage rat model is mediated by suppressing proinflammatory cytokines and downregulating cytosolic phospholipase A2 (cPLA2), 5-lipoxygenase (5-LOX), and the activation of calcitonin gene-related peptide. In this study, we evaluated the gastroprotective effects of SK-MS10 in the nonsteroidal anti-inflammatory drug (NSAID)-induced gastric damage rat model.

Methods: The pretreatment effect of SK-MS10 was evaluated in the NSAID-induced gastric damage rat model using aspirin, indomethacin, and diclofenac in 7-week-old rats. Gastric damage was evaluated based on the gross ulcer index by gastroenterologists, and the damage area (%) was measured using the MetaMorph 7.0 video image analysis system. Myeloperoxidase (MPO) was measured by enzyme-linked immunosorbent assay, and Western blotting was used to analyze the levels of cyclooxygenase (COX)-1, COX-2, cPLA2, and 5-LOX.

Results: All NSAIDs induced gastric damage based on the gross ulcer index and damage area (p<0.05). Gastric damage was significantly attenuated by SK-MS10 pretreatment compared with NSAID treatment alone (p<0.05). The SK-MS10 pretreatment group exhibited lower MPO levels than the diclofenac group. The expression of cPLA2 and 5-LOX was decreased by SK-MS10 pretreatment in each of the three NSAID treatment groups.

Conclusions: SK-MS10 exhibited a gastroprotective effect against NSAID-induced acute gastric damage in rats. However, its protective mechanism may be different across the three types of NSAID-induced gastric damage models in rats.

Keywords: Anti-inflammatory agents, non-steroidal; Arachidonate 5-lipoxygenase; Cochinchina momordica; Gastroprotection; Phospholipases A2, cytosolic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Arachidonate 5-Lipoxygenase / drug effects
  • Calcitonin Gene-Related Peptide / drug effects
  • Cyclooxygenase 1 / drug effects
  • Cyclooxygenase 2 / drug effects
  • Disease Models, Animal
  • Gastric Mucosa / chemistry
  • Gastric Mucosa / drug effects
  • Group IV Phospholipases A2 / drug effects
  • Male
  • Momordica / chemistry*
  • Peroxidase / drug effects
  • Plant Extracts / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Seeds / chemistry*
  • Stomach Ulcer / chemically induced
  • Stomach Ulcer / prevention & control*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Plant Extracts
  • Peroxidase
  • Arachidonate 5-Lipoxygenase
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Group IV Phospholipases A2
  • Calcitonin Gene-Related Peptide